Michael Wilkinson

Preventive cardiologist, lipidologist, and clinical researcher @UCSDHealth @UCSDMedSchool

[Michael Wilkinson @MWilkinsonMD]

🔥Immune-mediated inflammatory diseases & dyslipidemia intersect, drive CV risk

🏃‍♀️💊Targeted prevention can make a difference

@DrMichaelShapir
@atvbahajournals

@garshick @Bweber04 @CBallantyneMD @DrMarthaGulati @JohnKastelein @mdavidsonmd @lipiddoc

https://t.co/Ks5S37uEaF

[Michael Wilkinson @MWilkinsonMD]

🎉Our RCT in @ObesitySociety

10-hr TRE ➡️ ~3× more wt loss vs. standard of care in obesity over 12 wks

Exploratory adipose RNA-seq: ⬇️ inflammation

Meal timing matters

https://t.co/TStUD4IG2e

@PamTaubMD @SatchinPanda @EmilyManoogian @DrKristaVarady @salkinstitute @UCSDHealth

[Michael Wilkinson @MWilkinsonMD]

Test all adults for Lp(a)!

https://t.co/plftgMbkbT

@MarlysLPA @LipidJournal @nationallipid @foundationofnla @ACCinTouch @American_Heart @ASPCardio @DineshKalra @PamTaubMD @PamelaBMorris @rblument1 @EugeniaGianos @CBallantyneMD @hsbhatia @DrMichaelShapir @FamilyHeartFdn @Drlipid

[Michael Wilkinson @MWilkinsonMD]

@ljlaffin @JACCJournals Congrats @ljlaffin!

[National Lipid Association @nationallipid]

The NLA and @foundationofnla are on the floor at #ACC26! @ACCintouch

We're here for all the big discussions, especially around the 2026 ACC/AHA/Multisociety Dyslipidemia Guideline and the latest in #PreventiveCardiology.

Find us at booth 2353 for patient and clinician resources. Come say hi!👋

#Lipidology #Dyslipidemia #Cardiology

[Harpreet Bhatia @hsbhatia]

Enjoyed presenting our work on CAC in individuals with elevated Lp(a) at #ACC26

@UCSDCardiology @UCSDCardFellows @DrNathanWong

The full paper is available here @JACCJournals: https://t.co/5DJfrFG3kK

[Michael Wilkinson @MWilkinsonMD]

Congratulations @PamTaubMD and co-investigators on the RECOVER trial - huge accomplishment and much needed study @NIH #ACC26 #longCOVID #POTS @ACCinTouch @dranulala @CBallantyneMD @DLBHATTMD @UCSDHealth @Drroxmehran

[Harpreet Bhatia @hsbhatia]

Out now @JACCJournals, our new study on the use of CAC scoring in individuals with elevated Lp(a)

1/5

@UCSDCardiology @UCSDCardFellows @FamilyHeartFdn @ASPCardio @AlexRazavi @MattRamsisMD @MWilkinsonMD @PamTaubMD @khurramn1 @MichaelJBlaha @DrNathanWong

https://t.co/GnyqgGdiTy

[National Lipid Association @nationallipid]

New to the field of lipidology and looking to jumpstart your career?🚀

Hear from Lipid Scholarship Recipient Lonnell Gant-Adenyi, DNP as she shares how attending #NLASessions helped shape her path in cardiometabolic care.

If you're an early-career clinician interested in lipidology, this is the place to learn, connect, and grow!🌟

Register now: https://t.co/3guYfVoQeQ

#Lipidology #PreventiveCardiology #MedicalEducation #HealthcareProfessionals

[Michael Wilkinson @MWilkinsonMD]

@CBallantyneMD @DineshKalra @foundationofnla @carolkirkpat3 @PamTaubMD @hsbhatia @lipiddoc

[National Lipid Association @nationallipid]

A team-based approach is essential to improving outcomes in clinical lipidology and cardiometabolic care.🤝

In this must-watch episode of Lipid Insights, Mary Katherine Cheeley, PharmD, CLS, FNLA, and Michael Wilkinson, MD, FNLA join guest host Daniel E. Soffer, MD, MNLA to break down what it takes to build an effective, collaborative care team.

It’s a standout conversation from last season and one worth revisiting.🙌

Watch or listen on YouTube or your favorite podcast platform!

@dan_soffer @MWilkinsonMD

[National Lipid Association @nationallipid]

Should you test for Lp(a) more than once? #HeartMonth

@AKulkarniMD, alongside guests @dan_soffer and @MWilkinsonMD, breaks down the answer and more on this CME-accredited episode of Lipid Insights.

Tune in on your favorite podcast platform and claim credit at https://t.co/NRX649LI0Y.

[Archna Bajaj @ArchnaBajajMD]

Less than 2 weeks away, sign up for this all virtual half-day CME symposium on Feb 6 for you to learn all about Lp(a). Great line up of speakers! And live-streamed sessions to answer your questions. Register here: https://t.co/y9FKgs0x6v

[UC San Diego Cardiology @UCSDCardiology]

New publication from UC San Diego BEACON @MattRamsisMD @hsbhatia @PamTaubMD @MWilkinsonMD @JSCVD2

Lipoprotein(a) testing trends in young ischemic stroke patients from 2015-2024: An analysis of 188,000 individuals

@UCSDCardFellows @UCSDHealthSci

https://t.co/bg2QrnIsDi

[Michael Wilkinson @MWilkinsonMD]

@lipiddoc @AKulkarniMD @dan_soffer @PamTaubMD @hsbhatia @MattRamsisMD @UCSDHealth @CBallantyneMD @ArchnaBajajMD @MarlysLPA @EugeniaGianos

[National Lipid Association @nationallipid]

What’s the difference between today’s Lp(a) clinical trials? @MWilkinsonMD breaks it down in this Lipid Insights episode dedicated to all things Lp(a).

Listen to the full episode (S6 E10) and earn CME/CE credit at https://t.co/TtLsowkNr0.🎧

[UC San Diego Cardiology @UCSDCardiology]

New publication @MWilkinsonMD @JACCJournals:

Therapeutic Plasma Exchange and Evinacumab for Homozygous Familial Hypercholesterolemia

@UCSDCardFellows @UCSDHealthSci

https://t.co/tBEpILfWHX

[Harpreet Bhatia @hsbhatia]

We conducted a multi-center study from UC San Diego BEACON to evaluate real-world lowering of Lp(a) with PCSK9i and predictors of response

🧵 below

@EJPCEiC @UCSDCardiology @UCSDCardFellows @ESC_Journals @MWilkinsonMD @PamTaubMD @MattRamsisMD

https://t.co/cgQm7zIvpE

[Michael Wilkinson @MWilkinsonMD]

Unique, challenging case of homozygous familial hypercholesterolemia (HoFH)

Proud of our team @UCSDHealth!

https://t.co/xsk2XNdf96

@sawyeraygani @AlexVaioSykesMD

@JACCJournals @PamelaBMorris @nationallipid @ASPCardio @FamilyHeartFdn @PamTaubMD @CBallantyneMD @MichaelDShapiro

[UC San Diego Cardiology Fellows @UCSDCardFellows]

🚨 New paper from @UCSDCardiology all-star attending Dr. @MattRamsisMD and the UCSD Beacon Center. @hsbhatia @PamTaubMD @MWilkinsonMD

https://t.co/pUU0KQhufH

[Archna Bajaj @ArchnaBajajMD]

Remember to register for the half-day all virtual CME program about Lp(a) hosted by the Penn Lipid Clinic! Great line-up of speakers and live-steamed Q&A. @Lpa_Doc @MWilkinsonMD @DrMichaelShapir @ErinMichos @grsoffer @nationallipid @hillypaige2 @PennCardiology

[Maya S Safarova, MD, PhD @DrSafarova]

N >80k with #WES
🧬 Only 31% of confirmed genetic diagnoses of FH satisfied clinical (Dutch lipid clinic network) criteria for a diagnosis #knowFH
@MWilkinsonMD @lipiddoc @carolkirkpat3 @nationallipid
https://t.co/yBq6hbq5eD

[Dinesh Kalra, MD @DineshKalra]

LDL-C guidelines, goals and strategies simplified for the busy clinician. @CBallantyneMD @MWilkinsonMD @UofLCardiology @UofLMedicine @kentuckyacc @drpablocorral @Drlipid @LipidLover1030